These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


95 related items for PubMed ID: 183037

  • 1. Studies on a test vaccine for equine influenza virus. II. Field trials.
    Nagamine T, Asahara T, Ide S, Yoshimura M, Igarashi Y.
    Kitasato Arch Exp Med; 1975 Sep; 48(2-3):69-82. PubMed ID: 183037
    [No Abstract] [Full Text] [Related]

  • 2. Studies on a test vaccine for equine influenza virus. I. Production of a test vaccine.
    Nagamine T, Asahara T, Higashihara M, Igarashi Y.
    Kitasato Arch Exp Med; 1975 Sep; 48(2-3):53-67. PubMed ID: 183036
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG, Pouwels HG, van Loon AA.
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [Abstract] [Full Text] [Related]

  • 4. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):67-80. PubMed ID: 16476488
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.
    Morley PS, Townsend HG, Bogdan JR, Haines DM.
    J Am Vet Med Assoc; 1999 Jul 01; 215(1):61-6. PubMed ID: 10397067
    [Abstract] [Full Text] [Related]

  • 6. Authors do not believe article provides evidence of vaccine efficacy.
    Morley PS, Townsend HG, Haines DM.
    Am J Vet Res; 2001 May 01; 62(5):648. PubMed ID: 11341378
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
    Heldens JG, Pouwels HG, Derks CG, Van de Zande SM, Hoeijmakers MJ.
    Vaccine; 2009 Sep 04; 27(40):5530-7. PubMed ID: 19607950
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A serologic study of equine influenza.
    Halterman LG, McQueen JL.
    J Am Vet Med Assoc; 1968 Oct 15; 153(8):1069-73. PubMed ID: 5693156
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R, Grimmett H, Elton D, Daly JM.
    Vet Res; 2008 Oct 15; 39(3):21. PubMed ID: 18252187
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.